A β1-adrenergic agonist. Prepn: K. A. Jaeggi et al., DE 2503968 corresp to US 3978041 and US 4049797 (1974, 1976, 1977, all to Ciba-Geigy). Pharmacologic study: E. Carlsson et al., Arch. Pharmacol. 300, 101 (1977). Metabolism, hemodynamic effects, pharmacokinetics in man: O. R"onn et al., Eur. J. Clin. Pharmacol. 17, 81 (1980). Cardiovascular effects: D. H. Scott et al., Br. J. Clin. Pharmacol. 7, 365 (1979). Clinical study in coronary heart disease: I. Hutton et al., Br. Heart J. 43, 134 (1980). See also T. P. Kenakin, D. Beek, J. Pharmacol. Exp. Ther. 213, 406 (1980) for a discussion of the selectivity of action. Prepns of the racemic mixture: NL 6409883 corresp to H. K"oppe et al., US 3637852 (1965, 1972 both to Boehringer, Ing.); NL 301580 corresp to A. F. Crowther, L. H. Smith, US 3501769 (1965, 1970 both to ICI); A. F. Crowther et al., J. Med. Chem. 12, 638 (1969). Symposium: Acta Med. Scand. Suppl. 659, 1-325 (1982).
Cardiotonic.
β-Adrenergic Agonist; Cardiotonic